The Press Release Resource

• Tweet

• Tweet

Shanghai-Based Biotech startup, Nano Med Tech, have been featured in the Chinese press this week, publicizing a proposed national medical research forum, in what are seemingly the firms initial attempts at creating a public image.

After initially wetting the appetite of the speculators through 2009, news of Nano Med Techs progress dried up for some time as they persevered with FDA governance. However, the group has resurfaced as a possible IPO-entity again this week, with some genuinely positive news for the optimists.

In a small piece with a Beijing-based journalist, a spokesperson from the firm gave some preliminary details on the firm’s latest concept – one which some emerging market analysts have earmarked as the first clear indication that the research outfit are targeting a public offering.

In what is clearly a break from Nano Med Techs typically clandestine approach to the press so far, their spokesperson informed Chinese readers that the firm was committed to the concept of a national bio-research database as a means of promoting the value of research to the vast Chinese youth.

The spokesperson also made reference to the potential for information-sharing and exchange programs or internship arrangements between the U.S. and China, a statement which has already been described by several analyst bloggers as a clear move to give the firm a public profile, both in their domestic arena, but, more significantly, among the international markets, which have always been traditionally more welcoming to startups when it has come to funding.

However, the Nano Med Tech spokesperson fell short of offering a timetabled launch plan for the project, which will be in the form of a registration-based online repository and forum – explaining that the project was, admittedly, their number two priority after the ongoing FDA product approval, of which the Nano Med Tech spokesperson declined to make comment.